03 9370 3322
03 9370 3677
73 Union Road
Ascot Vale, VIC 3032
COVID19 VACCINATION CLINICS
Ascot Vale Health Group are pleased to announce we will be participating in the Covid19 Vaccination roll-out.
Phase 1B will commence Tuesday 23rd March 2021.
Our clinics will run Tuesday - Friday:
10.00am - 11.00am
12noon - 1.00pm
2.00pm - 3.00pm
Appointments are essential and can only be made by
telephoning the clinic - 9370 3322
Phase 1B - Eligibility criteria
Phase 1b priority population groups include:
people 70 years of age or older;
health care workers;
Aboriginal and Torres Strait Islander adults over 55 years;
Younger people with an underlying medical condition, including people with a disability; and
critical and high risk workers, including Australian Government officials about to be deployed overseas on official government business.
Please note: People who are not eligible for Medicare can still receive a free COVID-19 vaccination service at a General Practitioner led Respiratory Clinic or at a state or territory vaccination clinic.
Before you can receive the vaccine, the person giving you the vaccine needs to be able to satisfy
themself of your eligibility.
You will need to bring one of the following (as relevant to the criteria of eligibility that you meet) as
evidence for the vaccine provider to confirm your eligibility:
1. a current work ID card showing employment at a relevant occupation for Phase 1A or 1B;
2. a letter from your employer confirming that you are currently employed in a priority occupation
for Phase 1A or 1B;
3. documentation confirming you are a carer;
4. for household contacts of a quarantine / border worker, proof of occupation of the quarantine /
border worker and evidence to demonstrate you live at the same residential address. For
instance, this could include: bills or rates notices with both of your names and address, or
separate documentary evidence that shows each of your names while showing the same
5. details to enable the vaccine provider to access your MyHealth Record, if you have one;
6. a referral from your GP or treating specialist confirming that you have been diagnosed with
one or more of the relevant medical conditions, or have undergone or are undergoing one or
more of the procedures for Phase 1B;
7. proof in the form of an alternative medical record that is dated within the last 5 years which
shows that you have received the relevant diagnosis for the medical condition or have
undergone or are undergoing the procedure for Phase 1B. This includes:
• a printout of your medical history as recorded in your clinical records – i.e. your
patient medical summary as printed out from your GP’s practice;
• a printout of your chronic disease care plan from your GP;
• a discharge summary from a hospital or other medical facility; or
• a script in your name for a medication that you have been prescribed to treat one or
more of the relevant medical conditions or one or more of the procedures in the form
8. a condition-specific identifier that you have been issued with, such as a National Diabetes
Services Scheme membership card; or
Phases 2 and 3 - Rollout dates for phases 2 & 3 are yet to be confirmed
Phase 2 is also divided into two sections, 2a and 2b.
Phase 2a will include up to 15.8 million doses. The eligible population groups include:
Phase 2b will include up to 16 million doses and will be delivered to all remaining people ≥18 years of age.
Phase 3 may then include all of those who are under 18 years of age if the vaccine is recommended. Up to 13.6 million doses will be required for Phase 3. Currently, COVID-19 vaccines are only recommended to those 18 years and over in Australia (DoH, 2021b).
Find information in your language here - https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/covid-19-vaccine-information-in-your-language
COVID 19 – COMMON QUESTIONS & ANSWERS
The various vaccine have been developed too quickly – How can we be sure it is safe?
What are the possible side-effects of the vaccines?
Can you get COVID-19 from the different vaccines and can the vaccines change your genetic code?
Now that I have received the vaccine, do I still need to follow physical distancing and wear a mask when recommended?
Should I take paracetamol or ibuprofen before and after the COVID-19 vaccination?
Can I get my influenza vaccine at the same time as my COVID-19 vaccine?
Will the vaccines prevent COVID-19 infection or just severe symptoms?
The AstraZeneca/University of Oxford COVID-19 vaccine also requires two doses, given around 12 weeks apart (or as short as 4 weeks apart, if necessary). Refer to ATAGI clinical guidance on COVID-19 Vaccine in Australia in 2021 for more details on dose timing.
If the second dose of COVID-19 Vaccine AstraZeneca is overdue (i.e. past the preferred interval), that second dose should be given as soon as possible. A single dose is likely to only provide short-term protection. The second dose will be effective regardless of how late it is given. Even if the second dose is late, no vaccine doses need to be repeated.
Additional or booster doses beyond the two-dose course are not currently recommended. The need for any additional doses will be reviewed over time.
Certain viruses, including the novel coronavirus, SARS-CoV-2, naturally mutate over time. Often these mutations don’t impact how viruses affect us. However, some recent variants of SARS-CoV-2 are more easily spread and appear to be associated with increased numbers of cases in some countries.
Current evidence from clinical trials indicates that the antibodies induced from COVID-19 vaccines are likely to provide protection to a variety of mutations and minor changes. However, in some cases there may be an impact on how antibody developed from vaccines based on the original strain can ‘neutralise’ the virus. This may mean that the effectiveness of the current vaccines against this particular strain could be affected. This information is still emerging and is being closely monitored.
In the same way that the influenza vaccine changes each season, the technology used to create the COVID-19 vaccines may be able to be adapted to changes in variants.
As clinical trials are ongoing, and people have only started to be vaccinated in some other countries since around December 2020, we do not yet know how long immunity from the COVID-19 vaccine will last. We will gather more information about the duration of protection over the coming months.
The COVID-19 vaccines we will have in Australia have already been shown to be safe and effective, and it is strongly recommended to get vaccinated as soon as you are offered a vaccine.
Having a COVID-19 vaccine now offers you and others protection against the disease and is the fastest way to reducing our need for strict COVID-19 related measures.
Having one course of COVID-19 vaccination now will not mean you will not be eligible to have another COVID-19 vaccine in future – it is possible that additional or booster doses of vaccine are needed in the future. More data will come on this over time.
It is important that the COVID-19 vaccine is available to the entire population, even people with a past history of COVID-19.
The vaccine clinical trials included some previously infected people (who had a blood test showing past infection). These people responded to the vaccine well. They had a good immune response and had similar mild and expected side effects to people who weren’t previously infected.
If you have previously been diagnosed with COVID-19, you should talk to your healthcare provider about the best time to have a COVID-19 vaccination. You may be advised to wait until around 6 months after you have recovered from COVID-19 to have your vaccine.
Your body will develop an immune response within 2–3 weeks after the first dose and will be partially protected. However, all people need a second dose to achieve maximum and longer lasting protection.
Some people who have just had one dose of the vaccine may develop COVID-19 disease. If you are infected and have only had one dose of vaccine, you will still be able to have the second dose of COVID-19 vaccine, but you may be advised to delay the second dose for around 6 months after you have recovered from COVID-19.
Some people may also develop COVID-19 disease after two doses; however, it is expected symptoms will not be severe. Further evidence is awaited that will provide more insight on this.
Children and adolescents under 18 years of age cannot have the AstraZeneca COVID-19 or Pfizer vaccine.
This is because we don’t have any clinical trial results yet to confirm that the vaccines are effective and safe in these age groups. Clinical trials in children are planned or underway, and in the future children may be able to receive both of these vaccines.
COVID-19 vaccines are not routinely recommended in pregnancy, because pregnant women have not been included in clinical trials. However, some pregnant women may still choose to be vaccinated after considering the benefits and risks of vaccination.
In particular, a pregnant woman may wish to be vaccinated if she has risk factors for severe illness from COVID-19 or if she is at high risk of exposure to COVID-19, for example, because of her occupation.
Women who are breastfeeding can have a COVID-19 vaccine, and they don’t need to stop breastfeeding after vaccination. There are no theoretical safety concerns about the currently available COVID-19 vaccines for breastfeeding women or their babies.
Women who are planning pregnancy can have a COVID-19 vaccine, and they don’t need to avoid becoming pregnant after vaccination.
Either of the COVID-19 vaccines approved in Australia – Pfizer or COVID-19 Vaccine AstraZeneca – is suitable for women who are pregnant, breastfeeding or planning pregnancy.
For more information it is advised that women talk to their healthcare provider and refer to the COVID-19 vaccination decision guide for women who are pregnant, breastfeeding or planning pregnancy.
Almost all people with allergies can have a COVID-19 vaccine. This includes people with food allergies, asthma or hayfever.
People who have had anaphylaxis (a type of severe allergic reaction) to a particular COVID-19 vaccine, or to an ingredient of a COVID-19 vaccine, should not have another dose of that vaccine. They may be able to have an alternative brand of COVID-19 vaccine.
For some people, precautions may be needed before vaccination, such as consulting an allergy specialist, being vaccinated in a facility which has medical staff and being observed for at least 30 minutes after vaccination.
This applies to people in the following groups:
If you have had anaphylaxis (a type of severe allergic reaction) to a previous dose of a COVID-19, or to one of its ingredients, you should not have that vaccine again. Your healthcare provider can help to determine whether it will be safe for you to have an alternative COVID-19 vaccine.
If you had a suspected allergic reaction which was not anaphylaxis after a COVID-19 vaccine, or to one of its ingredients, you may still be able to have the second dose of the vaccine, but in some cases precautions are needed such as a longer period of observation after vaccination or referral for allergy testing.
You can find out more about the ingredients in COVID-19 vaccines in the Consumer Medicine Information, which is available on the TGA website.
In general, medication should not be stopped before having a vaccine, but there are a few situations in which people might be advised to either delay vaccination or delay a particular medication:
People taking other medications should continue their regular treatment before and after vaccination.
All vaccines can cause side effects. Usually these are mild. Clinical trials of COVID-19 vaccines have reported side effects such as pain at the injection site, fever or muscle aches starting on the day or day after vaccination.
Comirnaty (Pfizer) is generally well tolerated and most side effects are mild and short-lived. COVID-19 Vaccine AstraZeneca can also cause side effects that are usually mild to moderate, appear within the first day after vaccination and generally go away within a few days. The most common side effects for both vaccines include pain at the injection site, tiredness, headache, muscle pain, chills, joint pain and fever. These side effects are temporary and go away without treatment in 1–2 days.